intestinal permeability

Blurring the picture in leaky gut research: how shortcomings of zonulin as a biomarker mislead the field of intestinal permeability
Lucas Massier, Rima Chakaroun, Peter Kovacs, John T. Heiker

Gut Sep 2021, 70 (9) 1801-1802; DOI: 10.1136/gutjnl-2020-323026
Mucus barrier, mucins and gut microbiota: the expected slimy partners?
Paola Paone, Patrice D Cani

Gut Dec 2020, 69 (12) 2232-2243; DOI: 10.1136/gutjnl-2020-322260
Obesity promotes a leaky gut, inflammation and pre-diabetes by lowering gut microbiota that metabolise ethanolamine
Han Fang, Rodrigo R e-Lacerda, Jonathan D Schertzer

Gut Oct 2023, 72 (10) 1809-1811; DOI: 10.1136/gutjnl-2023-329815
What to do about the leaky gut
Michael Camilleri, Adrian Vella

Gut Feb 2022, 71 (2) 424-435; DOI: 10.1136/gutjnl-2021-325428
Protective effect of metronidazole on uncoupling mitochondrial oxidative phosphorylation induced by NSAID: a new mechanism
A Z A Leite, A M Sipahi, A O M C Damião, A M M Coelho, A T Garcez, M C C Machado, C A Buchpiguel, F P Lopasso, M L Lordello, C L O Agostinho, A A Laudanna

Gut Feb 2001, 48 (2) 163-167; DOI: 10.1136/gut.48.2.163
The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor α in the pathogenesis of non-alcoholic steatohepatitis
A J Wigg, I C Roberts-Thomson, R B Dymock, P J McCarthy, R H Grose, A G Cummins

Gut Feb 2001, 48 (2) 206-211; DOI: 10.1136/gut.48.2.206
Mucosal barrier function and the commensal flora
R J Kennedy, S J Kirk, K R Gardiner

Gut Mar 2002, 50 (3) 441-442; DOI: 10.1136/gut.50.3.441
Modulation of colonic barrier function by the composition of the commensal flora in the rat
A García-Lafuente, M Antolín, F Guarner, E Crespo, J-R Malagelada

Gut Apr 2001, 48 (4) 503-507; DOI: 10.1136/gut.48.4.503
Glucagon-like peptide-2 enhances intestinal epithelial barrier function of both transcellular and paracellular pathways in the mouse
M A Benjamin, D M McKay, P-C Yang, H Cameron, M H Perdue

Gut Jul 2000, 47 (1) 112-119; DOI: 10.1136/gut.47.1.112
COX-2 inhibition with rofecoxib does not increase intestinal permeability in healthy subjects: a double blind crossover study comparing rofecoxib with placebo and indomethacin
G Sigthorsson, R Crane, T Simon, M Hoover, H Quan, J Bolognese, I Bjarnason

Gut Oct 2000, 47 (4) 527-532; DOI: 10.1136/gut.47.4.527

Main menu

intestinal permeability

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

intestinal permeability

Pages